⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEXX News
Lexaria Bioscience Corp. Common Stock
Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
accessnewswire.com
LEXX
Form 8-K
sec.gov
LEXX
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
accessnewswire.com
LEXX
LEXXW
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
accessnewswire.com
LEXX
Form 8-K
sec.gov
LEXX
Lexaria Receives USD$2.6 Million Tax Rebate Payment
accessnewswire.com
LEXX
DehydraTECH(TM)-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
accessnewswire.com
LEXX
Form 8-K
sec.gov
LEXX
Lexaria Enters a Material Transfer Agreement With PegBio
accessnewswire.com
LEXX
Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight
globenewswire.com
NVO
LLY
BMY
AXSM
JNJ
SNY
BIIB
ABBV
MRK
REGN
GILD
AMGN
AZN
TEVA
BHC
ALKS
VRTX
SRPT
CRIS
NTLA
EDIT
INCY
ACAD
ALNY
CYTK
IONS
EXAS
IDXX
VNDA
SUPN
RGNX
XOM
CVAC
BNTX
ARCT
MRNA
NBIX
ADPT
AVXL
IMUX
PRGS
RDNT
CRDF
ADSK
ANAB
ATRC
CLDX
CPRX
ESPR
EXEL
FGEN
GALT
GRFS
HRMY
IGC
INSM
KODK
LAKE
LCTX
LEXX
LPCN
MESO
MITK
MNKD
MSFT
MYGN
NEO
NVCR
NXPI
OCGN
OMER
ORCL
PACB
PFE
PLRX
PRGO
PSNL
PTGX
QGEN
RARE
ROST
RVMD
SEIC
SIGA
SMCI
SNOW
SOFI
SPRO
TGTX
TNDM
TXG
ULTA
VEEV
VKTX
VRNS
WVE
XRAY
ZBRA
ZNTL